Tone mix
Week by week 52 weeks
Share of Vertex Pharmaceuticals Inc's 441 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jul 20, 2026 · tone +98Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching+59
- Week of Apr 27, 2026 · tone -18Vertex Pharmaceuticals Incorporated (VRTX) PT Nudged Higher as RBC Updates Biotech Sector Outlook-57
- Week of Aug 10, 2026 · tone -14One Company's Clinical Miss Is Another's Moat: Vertex Rallies as Sionna's CF Bet Collapses-53
- Week of Feb 2, 2026 · tone +72WuXi Biologics Jumps On Pact With Vertex Pharma For T-Cell Engager In Autoimmune Disease+48
- Week of Mar 30, 2026 · tone +75Wells Fargo Raises Vertex Pharmaceuticals (VRTX) Price Target to $550+44
- Week of Oct 12, 2026 · tone -4Vertex Pharmaceuticals VRTX Drops 4.1%, Shedding ~$5 Billion in One Session-38
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Vertex Pharmaceuticals Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 27 | +46 |
| Last 30 sessions | 52 | +34 |
| Last 90 sessions | 149 | +39 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Friday, November 6, 2026
5 headlines, average tone +100: 5 positive, 0 neutral and 0 negative. Showing all 5.
- www.aol.com · 3 outletsPrediction: Vertex Pharmaceuticals Will Be 1 of the Best Biotech Stocks to Own Over the Next 5 YearsPositive
- www.themarketsdaily.com · 1 outletVertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $725.00Positive
- www.themarketsdaily.com · 1 outletVertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $619.00Positive
- www.dailypolitical.com · 1 outletVertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $563.00Positive
- www.dailypolitical.com · 1 outletVertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $600.00Positive
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Prediction: Vertex Pharmaceuticals Will Be 1 of the Best Biotech Stocks to Own Over the Next 5 Years | www.aol.com | 3 | Positive |
| Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $725.00 | www.themarketsdaily.com | 1 | Positive |
| Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $619.00 | www.themarketsdaily.com | 1 | Positive |
| Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $563.00 | www.dailypolitical.com | 1 | Positive |
| Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $600.00 | www.dailypolitical.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, November 5, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletResearch Analysts' Weekly Ratings Changes for Vertex Pharmaceuticals (VRTX)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Research Analysts' Weekly Ratings Changes for Vertex Pharmaceuticals (VRTX) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, November 4, 2026
11 headlines, average tone +31: 6 positive, 3 neutral and 2 negative. The 8 most widely carried stories are listed; the table holds all 11.
- 247wallst.com · 1 outletVertex Pharmaceuticals (VRTX) Drops 5% After Hours From $558 OpenNegative
- 247wallst.com · 1 outletVertex Pharmaceuticals Drops 4.3% After Q3 Earnings FilingNegative
- www.themarketsdaily.com · 1 outletRoyal Bank Of Canada Forecasts Strong Price Appreciation for Vertex Pharmaceuticals (NASDAQ:VRTX) StockPositive
- www.dailypolitical.com · 1 outletVertex Pharmaceuticals (NASDAQ:VRTX) Stock Gets Price Target Bump from JPMorgan Chase & Co.Positive
- www.themarketsdaily.com · 1 outletVertex Pharmaceuticals (NASDAQ:VRTX) Stock Price Target Raised at TD CowenPositive
- www.dailypolitical.com · 1 outletVertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00Positive
- www.biopharmadive.com · 1 outletVertex, ahead of FDA decision, calms fears surrounding kidney drugPositive
- www.dailypolitical.com · 1 outletVertex (NASDAQ: VRTX) raises revenue outlook, but Crinetics costs cut GAAP profitPositive
Show the table · 11 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Vertex Pharmaceuticals (VRTX) Drops 5% After Hours From $558 Open | 247wallst.com | 1 | Negative |
| Vertex Pharmaceuticals Drops 4.3% After Q3 Earnings Filing | 247wallst.com | 1 | Negative |
| Royal Bank Of Canada Forecasts Strong Price Appreciation for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock | www.themarketsdaily.com | 1 | Positive |
| Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Gets Price Target Bump from JPMorgan Chase & Co. | www.dailypolitical.com | 1 | Positive |
| Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price Target Raised at TD Cowen | www.themarketsdaily.com | 1 | Positive |
| Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $650.00 | www.dailypolitical.com | 1 | Positive |
| Vertex, ahead of FDA decision, calms fears surrounding kidney drug | www.biopharmadive.com | 1 | Positive |
| Vertex (NASDAQ: VRTX) raises revenue outlook, but Crinetics costs cut GAAP profit | www.dailypolitical.com | 1 | Positive |
| Vertex Pharmaceuticals Incorporated $VRTX Stock Acquired by Vise Technologies Inc. | www.themarketsdaily.com | 1 | Neutral |
| Contrasting Vertex Pharmaceuticals (NASDAQ:VRTX) & Werewolf Therapeutics (NASDAQ:HOWL) | www.tickerreport.com | 1 | Neutral |
| Vertex Pharmaceuticals Q3 Earnings Call Highlights | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, November 3, 2026
4 headlines, average tone +25: 1 positive, 3 neutral and 0 negative. Showing all 4.
- markets.financialcontent.com · 1 outletFinancialContent - Vertex Pharmaceuticals's (NASDAQ:VRTX) Q3 2026 sales top estimatesPositive
- www.fool.com · 1 outletVertex (VRTX) Q3 2026 Earnings Call TranscriptNeutral
- www.dailypolitical.com · 1 outletVertex Pharmaceuticals Q3 Earnings Call HighlightsNeutral
- www.themarketsdaily.com · 1 outletVertex Pharmaceuticals (NASDAQ:VRTX) Announces Earnings ResultsNeutral
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| FinancialContent - Vertex Pharmaceuticals's (NASDAQ:VRTX) Q3 2026 sales top estimates | markets.financialcontent.com | 1 | Positive |
| Vertex (VRTX) Q3 2026 Earnings Call Transcript | www.fool.com | 1 | Neutral |
| Vertex Pharmaceuticals Q3 Earnings Call Highlights | www.dailypolitical.com | 1 | Neutral |
| Vertex Pharmaceuticals (NASDAQ:VRTX) Announces Earnings Results | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, November 2, 2026
5 headlines, average tone +40: 2 positive, 3 neutral and 0 negative. Showing all 5.
- www.heraldseries.co.uk · 3 outletsVertex Pharmaceuticals to build research centre at HarwellPositive
- 247wallst.com · 1 outletVertex Pharmaceuticals Reaches $558.88, a Fresh 52-Week PeakPositive
- www.themarketsdaily.com · 1 outletVertex Pharmaceuticals Incorporated $VRTX Stock Sold by Sumitomo Mitsui Trust Group Inc.Neutral
- www.themarketsdaily.com · 1 outletMirae Asset Global Investments Co. Ltd. Makes New $116.63 Million Investment in Vertex Pharmaceuticals Incorporated $VRTXNeutral
- www.tickerreport.com · 1 outletHead to Head Survey: Vertex Pharmaceuticals (NASDAQ:VRTX) versus ACADIA Pharmaceuticals (NASDAQ:ACAD)Neutral
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Vertex Pharmaceuticals to build research centre at Harwell | www.heraldseries.co.uk | 3 | Positive |
| Vertex Pharmaceuticals Reaches $558.88, a Fresh 52-Week Peak | 247wallst.com | 1 | Positive |
| Vertex Pharmaceuticals Incorporated $VRTX Stock Sold by Sumitomo Mitsui Trust Group Inc. | www.themarketsdaily.com | 1 | Neutral |
| Mirae Asset Global Investments Co. Ltd. Makes New $116.63 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX | www.themarketsdaily.com | 1 | Neutral |
| Head to Head Survey: Vertex Pharmaceuticals (NASDAQ:VRTX) versus ACADIA Pharmaceuticals (NASDAQ:ACAD) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Vertex Pharmaceuticals Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.